DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Atreya CE, Van Cutsem E, Bendell JC. et al.
Updated efficacy of the MEK inhibitor trametinib (T), BRAF inhibitor dabrafenib (D), and anti-EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E mutated (BRAFm) metastatic colorectal cancer (mCRC).
J Clin Oncol 2015
33. Abstract 103
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.